Mitsubishi Chemical in Final Talks to Sell Pharmaceutical Unit to Bain Capital for $3.2 Billion
Investment firm Bain Capital is in talks to acquire Mitsubishi Tanabe Pharma, a unit of Japan's Mitsubishi Chemical Group, in a potential deal, according to people familiar with the matter.
The two companies are in the final stages of negotiations and the deal could be worth more than 500 billion yen, or about $3.2 billion.
Earlier, Nikkei reported that Mitsubishi Chemical had granted a U.S. investment fund the right of first refusal to acquire its pharmaceutical unit.
Meanwhile, Mitsubishi Chemical said in response to the Nikkei report that it had no announcement to make.
"We are constantly reviewing the ideal mix of all businesses across the group, including pharmaceuticals, and are considering all options, including divestitures, to drive reform," the company said in a statement.
Looking for chemical products? Let suppliers reach out to you!
2026-07-13
-
Paint & Coating Industry Overview Mar.2025
This issue provides analysis of the European and German coatings markets, as well as the latest monthly reports and price trends of coatings-related chemical raw materials. Support online permanent download.Published in: Mar.2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Mitsubishi Chemical to Halt Production of Key Epoxy Resin Grades by 2027
-
Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical Agree in Principle to Establish New Joint Venture to Restructure Ethylene Production in Western Japan
-
Mitsubishi Chemical Announces Expansion of Advanced Carbon Fiber Production Capacity in Japan and the United States
-
Mitsubishi Chemical Exits the Manufacturing of Polyester Resins for Printer Toners
-
Mitsubishi Chemical Invests in Australia’s Licella Holdings
-
ENEOS and Mitsubishi Chemical Complete Chemical Recycling Facility at Ibaraki Plant
-
Mitsubishi Chemical Nantong PMMA Plant to Relocate
-
Gelest, a Mitsubishi Chemical Group Company, Invests in Specialty Materials Production Facility in the United States
-
Mitsubishi Chemical Expands Flame-Retardant Compound Capacity in China and France
-
Mitsubishi Chemical Exits PET Bottle Business
Recommend Reading
-
Global Chemical Inventories Hit Critical Lows as Over 200 Chinese Companies Suspend Quotations
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
Chemicals Are Going Wild: Sulfur Surges 512%, Titanium Dioxide, Polyols and Sulfuric Acid Lose Control
-
Understand the New Rules to Enter the Market | ECHEMI × API China 2026 Overseas Pharmaceutical Market & Product Trends Conference Successfully Concluded
-
Rising Naphtha Prices in Japan Drive Up Costs for Diapers, Sanitary Products, and Cosmetics
-
Supply Recovery Limited & Cost Decline: PP Market Shakes and Faces Potential Drop
-
Maintenance Concentration Leads to Cost Decline; April PP Market Experiences Volatile Performance
-
Ethyl Acetate Prices Continue to Decline